The government is setting out to secure a supplementary budget for the introduction of ‘Evusheld (tixagevimab, cilgavimab),’ an antibody combination treatment used to prevent COVID-19 infection in the immunocompromised that see a low effect from vaccinations.

With the National Assembly also agreeing on the need to introduce Evusheld, its introduction will gain momentum as soon as the supplementary budget submitted by the government passes the National Assembly.

The government plans to hold a Cabinet Meeting on the afternoon of the 12th to pass the supplementary budget.

In the proposed supplementary budget, attention is focused on the budget managed by the Korea Disease C